Hope, VD, et al.
Healthcare seeking and hospital admissions by people who inject drugs in response to symptoms of injection site infections or injuries in three urban areas of England. Epidemiology & Infection. Published online:
Hope, V. Neglected infections, real harms: a global scoping of injection-related bacterial infections and responses. In Cook, C, The Global State of Harm Reduction: Key Issues for Broadening the Response, pp. 89–96. London: International Harm Reduction Association; 2010.
Evans-Brown, M, et al.
Human Enhancement Drugs: The Emerging Challenges to Public Health. Liverpool, North West Public Health Observatory, April 2012.
McVeigh, J, Evans-Brown, M, Bellis, MA. Human enhancement drugs and the pursuit of perfection. Adicciones
2012; 24: 185–190.
Evans-Brown, M, McVeigh, J. Injecting human growth hormone as a performance-enhancing drug – perspectives from the United Kingdom. Journal of Substance Use
2009; 14: 267–288.
Evans-Brown, M, et al.
Use of melanotan I and II in the general population. British Medical Journal
2009; 338: b566.
Advisory Council on the Misuse of Drugs. Consideration of the anabolic steroids report. London: Home Office, September 2010.
Llewellyn, W. William Llewellyn's Anabolics, 10th edn. Jupiter, FL: Molecular Nutrition, 2010, pp. 800.
Iversen, J, et al.
Are people who inject performance and image-enhancing drugs an increasing population of needle and syringe program attendees?
Drug and Alcohol Review
2013; 32: 205–207.
Larance, B, et al.
Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Drug and Alcohol Review
2008; 27: 679–686.
Christiansen, AV. Testing citizens training recreationally in gyms. In: McNamee, M, Møller, V, eds. Doping and Anti-doping Policy in Sport. Abingdon: Routledge, 2011, pp. 126–141.
Castillo, EM, Comstock, RD. Prevalence of use of performance-enhancing substances among United States adolescents. Pediatric Clinics of North America
2007; 54: 663–75.
Advisory Council on the Misuse of Drugs. Consideration of the anabolic steroids annexes. London: Home Office; September 2010.
Korkia, P, Stimson, G. Anabolic steroid use in Great Britain: an exploratory investigation. Final report to the Department of Health for England, Scotland and Wales. The Centre for Research on Drugs and Health Behaviour, October 1993.
Bolding, G, Sherr, L, Elford, J. Use of anabolic steroids and associated health risks among gay men attending London gyms. Addiction
2002; 97: 195–203.
Ip, EJ, et al.
The anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy
2011; 31: 757–766.
Marquis, CP, Maffulli, N. Anabolic steroid related abscess – a risk worth taking?
2006; 37: 451–454.
Gautschi, OP, Zellweger, R. Images in clinical medicine. Methicillin-resistant Staphylococcus aureus abscess after intramuscular steroid injection. New England Journal of Medicine
2006; 355: 713.
Dunn, F. Two cases of biceps injury in bodybuilders with initially misleading presentation. Emergency Medicine Journal
2002; 19: 461–462.
Evans, NA. Local complications of self administered anabolic steroid injections. British Association of Sport and Medicine
1997; 31: 349–350.
Crampin, AC, et al.
The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales. Epidemiology & Infection
1998; 121: 381–386.
Day, CA, et al.
Collaboration of Australian NSPs. Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey. Drug and Alcohol Review
2008; 27: 559–561.
Scott, MJ, Scott, MJ. HIV infection associated with injections of anabolic steroids. Journal of the American Medical Association
1989; 262: 207–208.
Rich, JD, et al.
Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter. American Journal of Gastroenterology
1998; 93: 1598.
Hope, VD, et al.
Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study. BMJ Open
2013; 3: e003207.
Simmonds, L, Coomber, R. Injecting drug users: a stigmatised and stigmatising population. International Journal of Drug Policy, 2009; 20: 121–130.
Hope, VD, et al.
HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years. AIDS
2005; 19: 1207–1214.
Marshall-Gradisnik, S, Green, R, Weatherby, RP. Anabolic androgenic steroids and their actions on natural killer cells. Central European Journal of Biology
2009; 4: 19–33.
Walker, J, Adams, B. Cutaneous manifestations of anabolic–androgenic steroid use in athletes. International Journal of Dermatology
2009; 48: 1044–1048.
Duchaine, D. The Underground Steroid Handbook II (incorporating material from the original Underground Steroid Handbook, Ultimate Muscle Mass, and the USH updates nos. 1–10). Venice, CA: HLR Technical Books, 1989, pp. 95.
McVeigh, J, Lenehan, P. Gym owners opinions on performance enhancing drugs. Relay
1995; 1: 19–20.
Evans-Brown, M, Kimergård, A, McVeigh, J. Elephant in the room? The methodological implications for public health research of performance-enhancing drugs derived from the illicit market. Drug Testing and Analysis
2009; 1: 323–326.
Burton, C. Anabolic steroid use among the gym population in Clwyd. The Pharmaceutical Journal
1996; 256: 557–559.
Morrison, A, Elliott, L, Gruer, L. Injecting-related harm and treatment seeking behaviour among injecting drug users. Addiction
1997; 92: 1349–1352.
Nicoll, LH, Hesby, A. Intramuscular injection: An integrative research review and guideline for evidence-based practice. Applied Nursing Research. 2002; 16: 149–162.
Farkash, U, Shabshin, N, Pritsch (Perry), M. Rhabdomyolysis of the deltoid muscle in a bodybuilder using anabolic-androgenic steroids: a case report. Journal of Athletic Training
2009; 44: 98–100.
Akhavani, MA, Pacifico, MD, Kang, NV. Compartment syndrome of the forearm following intramuscular injection of an anabolic steroid. Injury Extra
2006; 37: 407–408.
Newland, J, Treloar, C. Peer education for people who inject drugs in New South Wales: Advantages, unanticipated benefits and challenges. Drugs: Education, Prevention and Policy
2013; 20: 304–311.
Rhodes, T. HIV outreach, peer education and community change: developments and dilemmas. Health Education Journal
1994; 53: 92–99.